Table of Contents 1 Market Overview 1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Preface 1.2.3 Eluxadoline 1.2.4 Alosetron 1.2.5 Rifaximin 1.2.6 Loperamide 1.2.7 Diphenoxylate + Atropine 1.2.8 Dicyclomine and Hyoscyamine 1.3 Market Analysis by Application 1.3.1 Overview: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Overview of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market 1.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Astellas Pharmaceuticals 2.1.1 Astellas Pharmaceuticals Details 2.1.2 Astellas Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Astellas Pharmaceuticals SWOT Analysis 2.1.4 Astellas Pharmaceuticals Product and Services 2.1.5 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 GlaxoSmithKline 2.2.1 GlaxoSmithKline Details 2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 GlaxoSmithKline SWOT Analysis 2.2.4 GlaxoSmithKline Product and Services 2.2.5 GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Actavis 2.3.1 Actavis Details 2.3.2 Actavis Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Actavis SWOT Analysis 2.3.4 Actavis Product and Services 2.3.5 Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 Pfizer 2.4.1 Pfizer Details 2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Pfizer SWOT Analysis 2.4.4 Pfizer Product and Services 2.4.5 Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 AstraZenenca 2.5.1 AstraZenenca Details 2.5.2 AstraZenenca Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 AstraZenenca SWOT Analysis 2.5.4 AstraZenenca Product and Services 2.5.5 AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 Salix Pharmaceuticals Ltd 2.6.1 Salix Pharmaceuticals Ltd Details 2.6.2 Salix Pharmaceuticals Ltd Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Salix Pharmaceuticals Ltd SWOT Analysis 2.6.4 Salix Pharmaceuticals Ltd Product and Services 2.6.5 Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturer Market Share in 2019 3.3.2 Top 6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Market Share by Regions 4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Regions (2015-2020) 4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Regions (2015-2020) 4.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 4.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 4.5 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Market Share by Country 5.1.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Country (2015-2020) 5.1.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Country (2015-2020) 5.2 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 5.3 Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 5.4 Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Market Share by Country 6.1.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Country (2015-2020) 6.1.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Country (2015-2020) 6.2 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 6.3 UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 6.4 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 6.5 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 6.6 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Regions (2015-2020) 7.2 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 7.3 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 7.4 Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 7.5 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 7.7 Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Market Share by Country 8.1.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Country (2015-2020) 8.1.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Country (2015-2020) 8.2 Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 8.3 Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 9.3 Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 9.4 Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 9.5 South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Market Share by Type (2015-2020) 10.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Market Share by Type (2015-2020) 10.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2015-2020) 11 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment by Application 11.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2015-2020) 11.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Application (2015-2020) 11.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Application (2015-2020) 12 Market Forecast 12.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Revenue and Growth Rate (2021-2025) 12.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by Regions (2021-2025) 12.2.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) 12.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) 12.2.3 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) 12.2.4 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) 12.2.5 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) 12.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by Type (2021-2025) 12.3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2021-2025) 12.3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Forecast by Type (2021-2025) 12.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by Application (2021-2025) 12.4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2021-2025) 12.4.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 8. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Business Table 9. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Total Revenue (USD Million) (2018-2019) Table 10. Astellas Pharmaceuticals SWOT Analysis Table 11. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services Table 12. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table 14. GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Business Table 15. GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Total Revenue (USD Million) (2018-2019) Table 16. GlaxoSmithKline SWOT Analysis Table 17. GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services Table 18. GlaxoSmithKline Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. Actavis Basic Information, Manufacturing Base and Competitors Table 20. Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Business Table 21. Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Total Revenue (USD Million) (2018-2019) Table 22. Actavis SWOT Analysis Table 23. Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services Table 24. Actavis Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. Pfizer Basic Information, Manufacturing Base and Competitors Table 26. Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Business Table 27. Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Total Revenue (USD Million) (2018-2019) Table 28. Pfizer SWOT Analysis Table 29. Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services Table 30. Pfizer Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. AstraZenenca Basic Information, Manufacturing Base and Competitors Table 32. AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Business Table 33. AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Total Revenue (USD Million) (2018-2019) Table 34. AstraZenenca SWOT Analysis Table 35. AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services Table 36. AstraZenenca Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 37. Salix Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors Table 38. Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Business Table 39. Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Total Revenue (USD Million) (2018-2019) Table 40. Salix Pharmaceuticals Ltd SWOT Analysis Table 41. Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services Table 42. Salix Pharmaceuticals Ltd Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 43. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturer (2018-2019) (K MT) Table 44. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturer (2018-2019) (USD Million) Table 45. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Regions (2015-2020) (K MT) Table 46. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions (2015-2020) Table 47. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions (2015-2020) (USD Million) Table 48. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2015-2020) (K MT) Table 49. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2015-2020) Table 50. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2015-2020) (USD Million) Table 51. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2015-2020) Table 52. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2015-2020) (K MT) Table 53. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2015-2020) Table 54. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2015-2020) (USD Million) Table 55. Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Regions (2015-2020) (K MT) Table 56. Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions (2015-2020) Table 57. Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Regions (2015-2020) (USD Million) Table 58. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2015-2020) (K MT) Table 59. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2015-2020) Table 60. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2015-2020) (USD Million) Table 61. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2015-2020) Table 62. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Countries (2015-2020) (K MT) Table 63. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2015-2020) Table 64. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Countries (2015-2020) (USD Million) Table 65. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2015-2020) Table 66. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (2015-2020) (K MT) Table 67. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Type (2015-2020) Table 68. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Type (2015-2020) (USD Million) Table 69. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Type (2015-2020) Table 70. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2015-2020) (K MT) Table 71. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Application (2015-2020) Table 72. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Regions (2021-2025) (K MT) Table 73. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Forecast by Regions (2021-2025) Table 74. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2021-2025) (K MT) Table 75. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Forecast by Type (2021-2025) Table 76. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2021-2025) Table 77. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Forecast by Application (2021-2025) Table 78. Direct Channel Pros & Cons Table 79. Indirect Channel Pros & Cons Table 80. Distributors/Traders/ Dealers List List of Figures Figure 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Picture Figure 2. Global Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2019 Figure 3. Preface Picture Figure 4. Eluxadoline Picture Figure 5. Alosetron Picture Figure 6. Rifaximin Picture Figure 7. Loperamide Picture Figure 8. Diphenoxylate + Atropine Picture Figure 9. Dicyclomine and Hyoscyamine Picture Figure 10. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application in 2018 Figure 11. Hospitals Picture Figure 12. Clinics Picture Figure 13. Others Picture Figure 14. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Status and Outlook (2015-2025) (USD Million) Figure 15. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 16. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 17. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 18. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 19. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 20. UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 21. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 22. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 23. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 24. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 25. Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 26. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 27. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 28. Australia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 29. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 30. Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 31. Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 32. South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 33. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 34. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Manufacturer in 2019 Figure 35. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Manufacturer in 2019 Figure 36. Top 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturer (Revenue) Market Share in 2019 Figure 37. Top 6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturer (Revenue) Market Share in 2019 Figure 38. Key Manufacturer Market Share Trend Figure 39. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 40. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 41. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions (2015-2020) Figure 42. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions in 2018 Figure 43. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) Figure 44. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) Figure 45. Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) Figure 46. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) Figure 47. Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) Figure 48. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 49. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries (2015-2020) Figure 50. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries in 2018 Figure 51. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2015-2020) (USD Million) Figure 52. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries in 2018 Figure 53. United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 54. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 55. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 56. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 57. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2015-2020) Figure 58. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries in 2019 Figure 59. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 60. UK Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 61. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 62. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 63. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 64. Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 65. Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Regions 2019 Figure 66. Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Regions 2019 Figure 67. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 68. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 69. Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 70. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 71. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 72. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 73. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries in 2019 Figure 74. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries in 2019 Figure 75. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 76. Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 77. Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 78. Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Countries in 2019 Figure 79. Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries (2015-2020) Figure 80. Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Countries in 2019 Figure 81. Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 82. Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 83. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 84. South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2015-2020) (K MT) Figure 85. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2021-2025) (K MT) Figure 86. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue and Growth Rate (2021-2025) (USD Million) Figure 87. North America Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) (K MT) Figure 88. Europe Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) (K MT) Figure 89. Asia-Pacific Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) (K MT) Figure 90. South America Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) (K MT) Figure 91. Middle East & Africa Sales Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast (2021-2025) (K MT) Figure 92. Sales Channel: Direct Channel vs Indirect Channel

Astellas Pharmaceuticals GlaxoSmithKline Actavis Pfizer AstraZenenca Salix Pharmaceuticals Ltd